These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 25053618)

  • 1. Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies.
    Walker GS; Bauman JN; Ryder TF; Smith EB; Spracklin DK; Obach RS
    Drug Metab Dispos; 2014 Oct; 42(10):1627-39. PubMed ID: 25053618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.
    Vishwanathan K; Babalola K; Wang J; Espina R; Yu L; Adedoyin A; Talaat R; Mutlib A; Scatina J
    Chem Res Toxicol; 2009 Feb; 22(2):311-22. PubMed ID: 19067650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of quantitative NMR in pharmacological evaluation of biologically generated metabolites: implications in drug discovery.
    Mutlib A; Espina R; Vishwanathan K; Babalola K; Chen Z; Dehnhardt C; Venkatesan A; Mansour T; Chaudhary I; Talaat R; Scatina J
    Drug Metab Dispos; 2011 Jan; 39(1):106-16. PubMed ID: 20952552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.
    Espina R; Yu L; Wang J; Tong Z; Vashishtha S; Talaat R; Scatina J; Mutlib A
    Chem Res Toxicol; 2009 Feb; 22(2):299-310. PubMed ID: 18980340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapy.
    Obach RS
    Pharmacol Rev; 2013 Apr; 65(2):578-640. PubMed ID: 23406671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolite identification in drug discovery.
    Watt AP; Mortishire-Smith RJ; Gerhard U; Thomas SR
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):57-65. PubMed ID: 12613277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternate strategies to obtain mass balance without the use of radiolabeled compounds: application of quantitative fluorine (19F) nuclear magnetic resonance (NMR) spectroscopy in metabolism studies.
    Mutlib A; Espina R; Atherton J; Wang J; Talaat R; Scatina J; Chandrasekaran A
    Chem Res Toxicol; 2012 Mar; 25(3):572-83. PubMed ID: 22292524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear magnetic resonance (NMR)-based drug metabolite profiling.
    Lenz EM
    Methods Mol Biol; 2011; 708():299-319. PubMed ID: 21207298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
    Tong W; Chowdhury SK; Su AD; Alton KB
    Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of isolated metabolites from drug metabolism studies as analytical standards by quantitative NMR.
    Walker GS; Ryder TF; Sharma R; Smith EB; Freund A
    Drug Metab Dispos; 2011 Mar; 39(3):433-40. PubMed ID: 21098098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dynamic nuclear polarization-NMR on blood plasma for assays of drug metabolism.
    Lerche MH; Meier S; Jensen PR; Hustvedt SO; Karlsson M; Duus JØ; Ardenkjaer-Larsen JH
    NMR Biomed; 2011 Jan; 24(1):96-103. PubMed ID: 20862657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications for Metabolite Quantification by Mass Spectrometry in the Absence of Authentic Standards.
    Hatsis P; Waters NJ; Argikar UA
    Drug Metab Dispos; 2017 May; 45(5):492-496. PubMed ID: 28254953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
    Srinivas NR
    Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of absolute quantitative (1)H NMR spectroscopy in drug discovery and development.
    Singh S; Roy R
    Expert Opin Drug Discov; 2016 Jul; 11(7):695-706. PubMed ID: 27187052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use and qualification of primary and secondary standards employed in quantitative ¹H NMR spectroscopy of pharmaceuticals.
    Rundlöf T; McEwen I; Johansson M; Arvidsson T
    J Pharm Biomed Anal; 2014 May; 93():111-7. PubMed ID: 24206940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accelerated metabolite identification by "extraction-NMR".
    Gerhard U; Thomas S; Mortishire-Smith R
    J Pharm Biomed Anal; 2003 Jul; 32(3):531-8. PubMed ID: 14565558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of lovastatin by rat and human liver microsomes in vitro.
    Greenspan MD; Yudkovitz JB; Alberts AW; Argenbright LS; Arison BH; Smith JL
    Drug Metab Dispos; 1988; 16(5):678-82. PubMed ID: 2906589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid chromatography/nuclear magnetic resonance spectroscopy and liquid chromatography/mass spectrometry identification of novel metabolites of the multidrug resistance modulator LY335979 in rat bile and human liver microsomal incubations.
    Ehlhardt WJ; Woodland JM; Baughman TM; Vandenbranden M; Wrighton SA; Kroin JS; Norman BH; Maple SR
    Drug Metab Dispos; 1998 Jan; 26(1):42-51. PubMed ID: 9443851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.